Search Results - "López Ferrer, A"

Real‐world drug survival of guselkumab, ixekizumab and secukinumab for psoriasis by Iznardo, H., Vilarrasa, E., López‐Ferrer, A., Puig, L.

“…Guselkumab is an IL-23 inhibitor approved for moderate-to-severe plaque psoriasis that has demonstrated safety and efficacy in phase III clinical trials …”
Get full text

Adalimumab for the treatment of psoriasis in real life: a retrospective cohort of 119 patients at a single Spanish centre by López-Ferrer, A., Vilarrasa, E., Gich, I.J., Puig, L.

“…Summary Background Patients with moderate‐to‐severe psoriasis treated with adalimumab in daily clinical practice are different from those in clinical trials,…”
Get full text

Definition of minimal disease activity in psoriasis by Carretero, G., Carrascosa, J.M., Puig, L., Sánchez‐Carazo, J.L., López‐Ferrer, A., Cueva, P., Soria, C., Rivera, R., Belinchón, I.

“…Objective To generate an operational definition to adequately reflect the construct ‘Minimal Disease Activity (MDA)’ in psoriasis. Methods A systematic review…”
Get full text

Long-term study of infliximab for psoriasis in daily practice: drug survival depends on combined treatment, obesity and infusion reactions by Spertino, J., López-Ferrer, A., Vilarrasa, E., Puig, L.

“…Background Infiximab has been shown to be highly effective in phase III clinical trials, but limited information is available regarding drug survival and…”
Get full text

The safety of ustekinumab for the treatment of psoriatic arthritis by López-Ferrer, A, Laiz, A, Puig, L

“…The cytokines interleukin (IL)-12 and IL-23 have been involved in the pathogenesis of psoriasis and psoriatic arthritis. Ustekinumab is a fully human…”
Get more information

Subclinical enthesopathy of extensor digitorum tendon is highly prevalent and associated with clinical and ultrasound alterations of the adjacent fingernails in patients with psoriatic disease by Moya Alvarado, P., Roé Crespo, E., Muñoz‐Garza, F.Z., López‐Ferrer, A., Laiz Alonso, A., Vilarrassa Rull, E., Casademont i Pou, J., Puig Sanz, L.

“…Background Nail psoriasis disease is associated with an increased probability of psoriatic arthritis, and its clinical signs may have different correlates with…”
Get full text

[Translated article] Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis by Puig, L., Notario, J., López-Ferrer, A., Scheneller-Pavelescu, L., Pérez, B., Galache, C., de la Cueva, P., Carrascosa, J.M.

“…[Display omitted] Several studies suggest that patients with psoriasis have a higher incidence of neoplasms, especially of the skin, which could be associated…”
Get full text

Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis by Puig, L, Notario, J, López-Ferrer, A, Scheneller-Pavelescu, L, Pérez, B, Galache, C, de la Cueva, P, Carrascosa, J M

“…Several studies suggest that patients with psoriasis have a higher incidence of neoplasms, especially of the skin, which could be associated with the use of…”
Get full text

Dermatologists' Role in the Early Diagnosis of Psoriatic Arthritis: Expert Recommendations by Belinchón, I, Salgado-Boquete, L, López-Ferrer, A, Ferran, M, Coto-Segura, P, Rivera, R, Vidal, D, Rodríguez, L, de la Cueva, P, Queiro, R

“…Psoriatic arthritis is a common type of inflammatory arthritis found in up to 40% of patients with psoriasis. Because skin involvement usually precedes joint…”
Get full text

Crusted (Norwegian) scabies: an under-recognized infestation characterized by an atypical presentation and delayed diagnosis by Yélamos, O., Mir-Bonafé, J.F., López-Ferrer, A., Garcia-Muret, M.P., Alegre, M., Puig, L.

Get full text

Source of Bias in the Spanish Language Version of the WPAI:PSO (Work Productivity and Activity Impairment-Psoriasis v. 2.0) Questionnaire by Margarit, E, López-Ferrer, A, Vilarrasa, E, Puig, L

Get full text

Psoriatic arthritis: an update by López-Ferrer, A, Laiz-Alonso, A

“…Advances in our understanding of the pathogenesis of psoriatic arthritis and clinical aspects of the disease justify the present review. Studies have…”
Get full text

Incremental cost-effectiveness ratio analysis of biologic treatments for psoriasis at clinically significant evaluation time points by Puig, L, López-Ferrer, A, Vilarrasa, E

Get full text

Model for assessing the efficiency of biologic drugs in the treatment of moderate to severe psoriasis for one year in clinical practice in Spain by Puig, L, López-Ferrer, A, Vilarrasa, E, García, I, Fernández-del Olmo, R

“…Most economic evaluations in the literature on the subject of biologic therapy for the treatment of psoriasis do not reflect normal clinical practice or…”
Get full text

Role of fucosyltransferases in the association between apomucin and Lewis antigen expression in normal and malignant gastric epithelium by López-Ferrer, A, de Bolós, C, Barranco, C, Garrido, M, Isern, J, Carlstedt, I, Reis, C A, Torrado, J, Real, F X

“…BACKGROUND In normal gastric epithelium, MUC5AC is detected in superficial epithelium associated with Lewis type 1 antigens and MUC6 is detected in antral…”
Get full text

Psoriatic Arthritis: What the Dermatologist Needs to Know, Part 2 by López-Ferrer, A., Torrente-Segarra, V., Puig, L.

“…This review aims to cover all aspects related to the treatment of psoriatic arthritis and the evaluation of the response to treatment. We define the various…”
Get full text

Initial results of ixekizumab efficacy and safety in real‐world plaque psoriasis patients: a multicentre retrospective study by Deza, G., Notario, J., Lopez‐Ferrer, A., Vilarrasa, E., Ferran, M., del Alcazar, E., Carrascosa, J.M., Corral, M., Salleras, M., Ribera, M., Puig, L., Pujol, R. M., Vidal, D., Gallardo, F.

“…Background Ixekizumab (anti‐IL17A) is effective as treatment for moderate‐to‐severe plaque psoriasis, but real‐life data on effectiveness and safety are…”
Get full text

Mucins as Differentiation Markers in Bronchial Epithelium . Squamous Cell Carcinoma and Adenocarcinoma Display Similar Expression Patterns by Lopez-Ferrer, Anna, Curull, Victor, Barranco, Carlos, Garrido, Marta, Lloreta, Josep, Real, Francisco X, de Bolos, Carme

“…Highly glycosylated apomucins are important to maintain the viscoelastic properties of the mucus. Changes in their expression are frequently associated with…”
Get full text

Real‐world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group by Alcázar, E., Suárez‐Pérez, J.A., Armesto, S., Rivera, R., Herrera‐Acosta, E., Herranz, P., Martín, I., Montesinos, E., Hospital, M., Vilarrasa, E., Ferran, M., Ruiz‐Villaverde, R., Sahuquillo‐Torralba, A., Ruiz‐Genao, D.P., Pérez‐Barrio, S., Muñoz, C., Llamas, M., Valentí, F., Mitxelena, M.J., López‐Ferrer, A., Carretero, G., Vidal, D., Mollet, J., Belinchón, I., Carrascosa, J.M.

“…Background Little has been published on the real‐world effectiveness and safety of apremilast in psoriasis. Objectives To evaluate the effectiveness, safety…”
Get full text

Psoriasis-Arthritis Units: Three Years On by López-Ferrer, A., Láiz-Alonso, A.

Get full text